Introduction to Behavioral Health: Definition and Scope Behavioral health represents a comprehensive paradigm encompassing the promotion of well-being, the prevention and treatment of mental illness, and the management of substance use disorders. It is a broad term that deliberately integrates psychological, behavioral, and biological factors that influence an individual’s overall health status. Unlike the often […]
Introduction and Conceptual Definition Behavioural addictions represent a class of disorders characterized by a persistent, compulsive engagement in non-substance-related activities, despite the individual experiencing significant adverse consequences. Unlike substance use disorders, where the addiction centers on the ingestion of psychoactive compounds, behavioural addictions involve excessive and often ritualistic engagement with intrinsically rewarding activities. The recognition […]
Introduction to Benzodiazepine Agonist Discontinuation The process of discontinuing benzodiazepine agonists represents a significant clinical challenge due to the high potential for physical dependence and the severity of associated withdrawal syndromes. Benzodiazepine agonists, widely prescribed for conditions such as generalized anxiety disorder, insomnia, and panic disorder, exert their therapeutic effects by enhancing the inhibitory neurotransmitter […]
Introduction: The Complexity of Benzodiazepine Discontinuation The clinical utility of benzodiazepine agonists (BZAs), including traditional benzodiazepines and Z-drugs, in managing acute anxiety and insomnia is well-established; however, their long-term use presents significant challenges, primarily revolving around the difficulty of safe and successful discontinuation. These agents exert their therapeutic effects by potentiating the inhibitory neurotransmitter gamma-aminobutyric […]
Introduction: Understanding Buprenorphine Discontinuation Buprenorphine, often prescribed as part of medication-assisted treatment (MAT) for opioid use disorder (OUD), represents a critical advancement in addiction medicine due to its partial agonist properties at the mu-opioid receptor. While highly effective in reducing cravings, preventing withdrawal, and blocking the euphoric effects of other opioids, the eventual decision to […]
Introduction to Contingency Management and Attitudinal Context Contingency Management (CM) represents a highly effective, evidence-based behavioral intervention rooted in the principles of operant conditioning, primarily applied within the treatment of Substance Use Disorders (SUDs). This method involves systematically providing tangible rewards or reinforcement contingent upon verifiable positive behavioral changes, most commonly documented abstinence from substance […]
Attitudes toward Forced Drug Treatment: Ethical and Empirical Considerations The debate surrounding forced drug treatment, or compulsory substance use disorder (SUD) treatment, represents one of the most persistent and complex ethical dilemmas in modern behavioral health policy. Compulsory treatment involves mandating an individual’s participation in rehabilitation or detoxification programs, often through judicial orders (e.g., drug […]
Introduction to Dual Diagnosis: AUD and Schizophrenia The co-occurrence of Alcohol Use Disorder (AUD) and Schizophrenia represents one of the most clinically challenging and prevalent dual diagnoses encountered within psychiatric practice, often termed co-occurring mental and substance use disorders. Schizophrenia, a chronic and severe mental illness characterized by profound disturbances in thought, emotion, and behavior, […]
The Conceptual Framework of Medication Assisted Treatment Medication Assisted Treatment (MAT) represents a comprehensive approach to treating substance use disorders (SUDs), particularly opioid use disorder (OUD) and alcohol use disorder (AUD), integrating pharmacological interventions with counseling and behavioral therapies. The core philosophy underpinning MAT is the recognition of addiction as a chronic, relapsing brain disease, […]
Defining Aberrant Opioid-Related Behaviors Aberrant Opioid-Related Behaviors (AORBs) refer to any behaviors related to the use of opioid medications that deviate significantly from the established norms of responsible medical practice, patient agreement, or prescribed dosage and frequency. In the context of chronic pain management, identifying these behaviors is critically important, as they serve as potential […]